APA

Yousef G. M., Kyriakopoulou L. G., Scorilas A., Fracchioli S., Ghiringhello B., Zarghooni M., Chang A., Diamandis M., Giardina G., Hartwick W. J., Richiardi G., Massobrio M., Diamandis E. P. & Katsaros D. (20011204). Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker. : Cancer research.

Chicago

Yousef G M, Kyriakopoulou L G, Scorilas A, Fracchioli S, Ghiringhello B, Zarghooni M, Chang A, Diamandis M, Giardina G, Hartwick W J, Richiardi G, Massobrio M, Diamandis E P and Katsaros D. 20011204. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker. : Cancer research.

Harvard

Yousef G. M., Kyriakopoulou L. G., Scorilas A., Fracchioli S., Ghiringhello B., Zarghooni M., Chang A., Diamandis M., Giardina G., Hartwick W. J., Richiardi G., Massobrio M., Diamandis E. P. and Katsaros D. (20011204). Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker. : Cancer research.

MLA

Yousef G M, Kyriakopoulou L G, Scorilas A, Fracchioli S, Ghiringhello B, Zarghooni M, Chang A, Diamandis M, Giardina G, Hartwick W J, Richiardi G, Massobrio M, Diamandis E P and Katsaros D. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker. : Cancer research. 20011204.